Posted in | News | Medical Robotics

Magellan Robotic System to be Exhibited at Transcatheter Cardiovascular Therapeutics Conference

Hansen Medical, a global leader in intravascular robotics, today announced it will exhibit its Magellan™ Robotic System at the Transcatheter Cardiovascular Therapeutics (TCT) conference, from October 22-26 at the Miami Beach Convention Center in Miami, FL. The Company will be conducting product demonstrations and exhibiting the Magellan Robotic System at Booth 895.

Additionally, Dr. Barry Katzen, founder and Medical Director of Baptist Cardiac & Vascular Institute (Baptist Hospital of Miami) is scheduled to feature the Magellan System in a live aortic endograft case at the conference on Wednesday, October 24 at 1:00 PM ET.

"We are pleased that our Magellan Robotic System will be further highlighted at TCT, which is the world's largest educational meeting focused on interventional vascular procedures," said Bruce Barclay, president and CEO of Hansen Medical. "Moreover, the live case scheduled to be performed by Dr. Katzen will provide an additional opportunity for those in the cardiovascular community to observe how the Magellan System can enhance endovascular procedures. Our strong presence at TCT combined with our recent and upcoming showings at the Vascular InterVentional Advances (VIVA) Conference and the 39th Annual Symposium on Vascular and Endovascular Issues (VEITHsymposium™), respectively, are critical opportunities for Hansen Medical to continue generating momentum around the significant benefits of our technology."

About the Magellan™ Robotic System

Hansen Medical's Magellan Robotic System is based upon the flexible robotic technology incorporated in the Sensei-X® Robotic Catheter System currently sold in the U.S. and Europe, which has been used in more than 8,000 patients, but includes a number of key enhancements. In particular, the Magellan Robotic System:

  • Provides solid catheter stability for placement of therapeutic devices.
  • Is designed to enable predictable procedure times and increased case throughput.
  • Allows for independent, individual robotic control of the distal tips of both the outer sheath and the inner leader catheter, as well as robotic manipulation of standard guidewires.
  • Is designed to allow for sufficient extension inside the body to access hard to reach peripheral anatomy.
  • Preserves the open architecture featured in the Sensei System to allow for the subsequent use of many 6F therapeutic devices on the market today.
  • Is designed to potentially reduce physician radiation exposure and fatigue by employing a remote physician workstation.

Source: http://www.hansenmedical.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Auris Surgical Robotics Inc.. (2019, February 20). Magellan Robotic System to be Exhibited at Transcatheter Cardiovascular Therapeutics Conference. AZoRobotics. Retrieved on May 22, 2024 from https://www.azorobotics.com/News.aspx?newsID=3336.

  • MLA

    Auris Surgical Robotics Inc.. "Magellan Robotic System to be Exhibited at Transcatheter Cardiovascular Therapeutics Conference". AZoRobotics. 22 May 2024. <https://www.azorobotics.com/News.aspx?newsID=3336>.

  • Chicago

    Auris Surgical Robotics Inc.. "Magellan Robotic System to be Exhibited at Transcatheter Cardiovascular Therapeutics Conference". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=3336. (accessed May 22, 2024).

  • Harvard

    Auris Surgical Robotics Inc.. 2019. Magellan Robotic System to be Exhibited at Transcatheter Cardiovascular Therapeutics Conference. AZoRobotics, viewed 22 May 2024, https://www.azorobotics.com/News.aspx?newsID=3336.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.